2-Bromomescaline
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with 2C-B (sometimes also referred to as "bromomescaline")
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
PubChem | CID 16637783 |
ChemSpider | 17574207 Y |
Chemical and physical data | |
Systematic (IUPAC) name: 2-(2-Bromo-3,4,5-trimethoxyphenyl)ethanamine
|
|
3D model (Jmol) | Interactive image |
Formula | C11H16BrNO3 |
Molar mass | 290.153 g/mol |
|
|
|
2-Bromomescaline (2-Br-M) is a derivative of the phenethylamine hallucinogen mescaline which has an unusual 2-bromo substitution.[1][2] It is an agonist for serotonin receptors, with a binding affinity of 215 nM at 5-HT1A, 513 nM at 5-HT2A and 379 nM at 5-HT2C, so while it is around ten times more tightly binding than mescaline at 5-HT1A and 5-HT2A receptors, it is over twenty times more potent at 5-HT2C.[3] Anecdotal reports in humans suggest it produces similar effects to mescaline, with around twice the potency but somewhat inferior effects.[4][unreliable source?]
See also[edit]
References[edit]
- ^ Pecherer B, Sunbury RC, Brossi A (1972). "Novel synthesis of aromatic methoxy and methylenedioxy-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines". J Het Chem. 9 (3): 609–616.
- ^ Alexander Shulgin; Tania Manning; Paul F Daley (2011). The Shulgin Index. Volume 1. Psychedelic Phenethylamines and Related Compounds. Transform Press. p. 280–281, 355. ISBN 978-0-9630096-3-0.
- ^ Daniel Trachsel; David Lehmann; Christoph Enzensperger (2013). Phenethylamine Von der Struktur zur Funktion. Nachtschatten Verlag AG. p. 908–910. ISBN 978-3-03788-700-4.
- ^ Dichloromescaline. Erowid.com, 2004
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Psychedelics (5-HT2A agonists) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
This Hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Chemical articles having calculated molecular weight overwritten
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles lacking reliable references
- Articles lacking reliable references from October 2015
- All stub articles